Conformation-X Therapeutics Bolts out of Stealth, Securing Over $13.5M in Funding to Propel Its Innovative Immune-Oncology Pipeline

[#item_full_content]CANTON, Mass.–(BUSINESS WIRE)– #cancer–Conformation-X Therapeutics secures over $13.5M in funding to advance its innovative immune-oncology pipeline.